Nathalie Auber
Sofinnova Investments, Inc.
Assets Managed
$2.631B
Holdings
69
Last Quarter
2026 - Q1
Filed Date
19d ago
Growth Rate
13.45%(2Q avg: 20.14%)
Sustained Growth
6 quarters
Portfolio positions
This chart displays the top 10 holdings in Sofinnova Investments, Inc.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 69 positions.
Assets under management
The assets under management (AUM) of Sofinnova Investments, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 6 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 2.631B in assets, with a quarterly growth rate of 13.45% and a 2-quarter average growth rate of 20.14%. The portfolio is managed by Nathalie Auber, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
NTRA Natera Inc
| 11.79% | $310.04M 1.55M shares@ $199.99 avg price | |
IWM Ishares Russell 2000 Etf
| 5.66% | $148.8M↓ Put 600,000 shares@ $248.0 avg price | New Position |
UTHR United Therapeutics Corp
| 5.42% | $142.535M↓ Put 240,370 shares@ $592.99 avg price | Increased 52.48% |
XBI Spdr S&p Biotech Etf
| 5.1% | $134.117M↓ Put 1.05M shares@ $127.73 avg price | New Position |
BMY Bristol-myers Squibb Co
| 4.59% | $120.616M 1.989M shares@ $60.66 avg price | Increased 31.45% |
JAZZ Jazz Pharmaceuticals Plc
| 4.3% | $113.114M 598,327 shares@ $189.05 avg price | Decreased -37.66% |
VERA Vera Therapeutics Inc
| 4.28% | $112.402M 2.794M shares@ $40.23 avg price | |
AZNCF Astrazeneca Plc
| 3.42% | $89.938M 456,031 shares@ $197.23 avg price | New Position |
QQQ Invesco Qqq Trust Series 1
| 3.3% | $86.577M↓ Put 150,000 shares@ $577.18 avg price | New Position |
COGT Cogent Biosciences Inc
| 3.1% | $81.351M 2.114M shares@ $38.5 avg price | Increased 7.09% |
1-10 of 69